nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A5—Diphenhydramine—atopic dermatitis	0.127	1	CbGbCtD
L-Carnitine—SLC25A29—neck—atopic dermatitis	0.0255	0.159	CbGeAlD
L-Carnitine—CROT—skin of body—atopic dermatitis	0.0151	0.0944	CbGeAlD
L-Carnitine—SLC25A20—skin of body—atopic dermatitis	0.0132	0.0821	CbGeAlD
L-Carnitine—CRAT—skin of body—atopic dermatitis	0.0128	0.0796	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—IL18R1—atopic dermatitis	0.0112	0.0971	CbGpPWpGaD
L-Carnitine—SLC25A29—head—atopic dermatitis	0.0108	0.0671	CbGeAlD
L-Carnitine—CROT—head—atopic dermatitis	0.00988	0.0616	CbGeAlD
L-Carnitine—CPT2—skin of body—atopic dermatitis	0.00983	0.0613	CbGeAlD
L-Carnitine—CES1—neck—atopic dermatitis	0.00902	0.0562	CbGeAlD
L-Carnitine—SLC25A20—head—atopic dermatitis	0.0086	0.0536	CbGeAlD
L-Carnitine—CRAT—head—atopic dermatitis	0.00834	0.052	CbGeAlD
L-Carnitine—SLC22A5—Temsirolimus—Tacrolimus—atopic dermatitis	0.00777	0.5	CbGdCrCtD
L-Carnitine—SLC22A5—Temsirolimus—Pimecrolimus—atopic dermatitis	0.00777	0.5	CbGdCrCtD
L-Carnitine—SLC22A4—neck—atopic dermatitis	0.00688	0.0429	CbGeAlD
L-Carnitine—CPT1A—head—atopic dermatitis	0.00676	0.0421	CbGeAlD
L-Carnitine—CPT2—head—atopic dermatitis	0.00642	0.04	CbGeAlD
L-Carnitine—XDH—Purine metabolism—ADSL—atopic dermatitis	0.00501	0.0435	CbGpPWpGaD
L-Carnitine—MPO—skin of body—atopic dermatitis	0.00488	0.0304	CbGeAlD
L-Carnitine—CPT2—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.00447	0.0388	CbGpPWpGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00407	0.0354	CbGpPWpGaD
L-Carnitine—CES1—head—atopic dermatitis	0.00381	0.0237	CbGeAlD
L-Carnitine—CPT1A—RORA activates circadian gene expression—PPARA—atopic dermatitis	0.0032	0.0278	CbGpPWpGaD
L-Carnitine—MPO—head—atopic dermatitis	0.00318	0.0198	CbGeAlD
L-Carnitine—CPT1A—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.0031	0.0269	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL17A—atopic dermatitis	0.003	0.0261	CbGpPWpGaD
L-Carnitine—SLC22A5—skin of body—atopic dermatitis	0.00295	0.0184	CbGeAlD
L-Carnitine—CPT1A—Circadian rythm related genes—RELB—atopic dermatitis	0.00288	0.0251	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00256	0.0223	CbGpPWpGaD
L-Carnitine—SLC22A8—head—atopic dermatitis	0.00254	0.0158	CbGeAlD
L-Carnitine—XDH—Nucleotide metabolism—ADSL—atopic dermatitis	0.00252	0.0219	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00213	0.0185	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL18—atopic dermatitis	0.00205	0.0178	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00185	0.0161	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00181	0.0157	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00181	0.0157	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian Clock—PPARA—atopic dermatitis	0.0017	0.0148	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.00159	0.0138	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—NFKBIA—atopic dermatitis	0.00157	0.0136	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00151	0.0131	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.00148	0.0128	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—PPARA—atopic dermatitis	0.00141	0.0122	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.00138	0.012	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.00136	0.0118	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.00125	0.0109	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL4—atopic dermatitis	0.00125	0.0109	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IFNG—atopic dermatitis	0.0012	0.0104	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00117	0.0101	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—CD4—atopic dermatitis	0.00116	0.0101	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00113	0.00984	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL1B—atopic dermatitis	0.00107	0.00931	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—atopic dermatitis	0.00107	0.00927	CbGpPWpGaD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00102	0.0089	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—NPS—atopic dermatitis	0.00102	0.00889	CbGpPWpGaD
L-Carnitine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000981	0.00169	CcSEcCtD
L-Carnitine—Haemorrhage—Prednisolone—atopic dermatitis	0.00098	0.00168	CcSEcCtD
L-Carnitine—Paraesthesia—Tacrolimus—atopic dermatitis	0.000979	0.00168	CcSEcCtD
L-Carnitine—CPT1A—PPARA activates gene expression—PPARA—atopic dermatitis	0.000977	0.00849	CbGpPWpGaD
L-Carnitine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000972	0.00167	CcSEcCtD
L-Carnitine—Pruritus—Mometasone—atopic dermatitis	0.000969	0.00166	CcSEcCtD
L-Carnitine—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000962	0.00165	CcSEcCtD
L-Carnitine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000959	0.00165	CcSEcCtD
L-Carnitine—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000957	0.00164	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.000956	0.00831	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000951	0.00826	CbGpPWpGaD
L-Carnitine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000948	0.00163	CcSEcCtD
L-Carnitine—CROT—Metabolism—GLB1—atopic dermatitis	0.000948	0.00824	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000948	0.00824	CbGpPWpGaD
L-Carnitine—Nausea—Loratadine—atopic dermatitis	0.000948	0.00163	CcSEcCtD
L-Carnitine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000947	0.00163	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000941	0.00162	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00094	0.00817	CbGpPWpGaD
L-Carnitine—Diarrhoea—Mometasone—atopic dermatitis	0.000937	0.00161	CcSEcCtD
L-Carnitine—Constipation—Tacrolimus—atopic dermatitis	0.000932	0.0016	CcSEcCtD
L-Carnitine—Pain—Tacrolimus—atopic dermatitis	0.000932	0.0016	CcSEcCtD
L-Carnitine—Weight increased—Betamethasone—atopic dermatitis	0.00093	0.0016	CcSEcCtD
L-Carnitine—Weight increased—Dexamethasone—atopic dermatitis	0.00093	0.0016	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000929	0.00807	CbGpPWpGaD
L-Carnitine—Weight decreased—Betamethasone—atopic dermatitis	0.000924	0.00159	CcSEcCtD
L-Carnitine—Weight decreased—Dexamethasone—atopic dermatitis	0.000924	0.00159	CcSEcCtD
L-Carnitine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000912	0.00157	CcSEcCtD
L-Carnitine—CROT—Metabolism—ADSL—atopic dermatitis	0.000909	0.0079	CbGpPWpGaD
L-Carnitine—Muscular weakness—Prednisone—atopic dermatitis	0.000908	0.00156	CcSEcCtD
L-Carnitine—Haemoglobin—Triamcinolone—atopic dermatitis	0.000906	0.00156	CcSEcCtD
L-Carnitine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000904	0.00155	CcSEcCtD
L-Carnitine—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000904	0.00155	CcSEcCtD
L-Carnitine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000903	0.00155	CcSEcCtD
L-Carnitine—Rhinitis—Triamcinolone—atopic dermatitis	0.000903	0.00155	CcSEcCtD
L-Carnitine—Rhinitis—Methylprednisolone—atopic dermatitis	0.000901	0.00155	CcSEcCtD
L-Carnitine—Haemorrhage—Triamcinolone—atopic dermatitis	0.000901	0.00155	CcSEcCtD
L-Carnitine—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000899	0.00154	CcSEcCtD
L-Carnitine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000898	0.00154	CcSEcCtD
L-Carnitine—Pharyngitis—Triamcinolone—atopic dermatitis	0.000894	0.00154	CcSEcCtD
L-Carnitine—Eye disorder—Hydrocortisone—atopic dermatitis	0.000894	0.00154	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000893	0.00776	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000891	0.00153	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisolone—atopic dermatitis	0.000875	0.0015	CcSEcCtD
L-Carnitine—Vomiting—Mometasone—atopic dermatitis	0.000871	0.0015	CcSEcCtD
L-Carnitine—Rash—Mometasone—atopic dermatitis	0.000863	0.00148	CcSEcCtD
L-Carnitine—Dermatitis—Mometasone—atopic dermatitis	0.000863	0.00148	CcSEcCtD
L-Carnitine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000862	0.00148	CcSEcCtD
L-Carnitine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000862	0.00148	CcSEcCtD
L-Carnitine—Headache—Mometasone—atopic dermatitis	0.000858	0.00147	CcSEcCtD
L-Carnitine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000855	0.00147	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000852	0.0074	CbGpPWpGaD
L-Carnitine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000852	0.00146	CcSEcCtD
L-Carnitine—Eye disorder—Methylprednisolone—atopic dermatitis	0.00084	0.00144	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000829	0.0072	CbGpPWpGaD
L-Carnitine—Haemoglobin—Betamethasone—atopic dermatitis	0.000822	0.00141	CcSEcCtD
L-Carnitine—Haemoglobin—Dexamethasone—atopic dermatitis	0.000822	0.00141	CcSEcCtD
L-Carnitine—Haemorrhage—Betamethasone—atopic dermatitis	0.000818	0.0014	CcSEcCtD
L-Carnitine—Haemorrhage—Dexamethasone—atopic dermatitis	0.000818	0.0014	CcSEcCtD
L-Carnitine—Angiopathy—Methylprednisolone—atopic dermatitis	0.000816	0.0014	CcSEcCtD
L-Carnitine—Nausea—Mometasone—atopic dermatitis	0.000813	0.0014	CcSEcCtD
L-Carnitine—Weight increased—Prednisone—atopic dermatitis	0.00081	0.00139	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000809	0.00703	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GLB1—atopic dermatitis	0.000806	0.00701	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GLB1—atopic dermatitis	0.000806	0.00701	CbGpPWpGaD
L-Carnitine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000805	0.00138	CcSEcCtD
L-Carnitine—Weight decreased—Prednisone—atopic dermatitis	0.000805	0.00138	CcSEcCtD
L-Carnitine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000803	0.00138	CcSEcCtD
L-Carnitine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000803	0.00138	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.000792	0.00688	CbGpPWpGaD
L-Carnitine—Depression—Prednisone—atopic dermatitis	0.000791	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Tacrolimus—atopic dermatitis	0.000782	0.00134	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—atopic dermatitis	0.000777	0.00675	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ADSL—atopic dermatitis	0.000773	0.00672	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ADSL—atopic dermatitis	0.000773	0.00672	CbGpPWpGaD
L-Carnitine—Pruritus—Tacrolimus—atopic dermatitis	0.000771	0.00132	CcSEcCtD
L-Carnitine—Dysgeusia—Triamcinolone—atopic dermatitis	0.000768	0.00132	CcSEcCtD
L-Carnitine—Vertigo—Prednisolone—atopic dermatitis	0.000766	0.00132	CcSEcCtD
L-Carnitine—Eye disorder—Betamethasone—atopic dermatitis	0.000764	0.00131	CcSEcCtD
L-Carnitine—Eye disorder—Dexamethasone—atopic dermatitis	0.000764	0.00131	CcSEcCtD
L-Carnitine—Back pain—Triamcinolone—atopic dermatitis	0.000759	0.0013	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IFNG—atopic dermatitis	0.000756	0.00657	CbGpPWpGaD
L-Carnitine—Vertigo—Hydrocortisone—atopic dermatitis	0.000748	0.00129	CcSEcCtD
L-Carnitine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000746	0.00128	CcSEcCtD
L-Carnitine—Angiopathy—Dexamethasone—atopic dermatitis	0.000742	0.00127	CcSEcCtD
L-Carnitine—Angiopathy—Betamethasone—atopic dermatitis	0.000742	0.00127	CcSEcCtD
L-Carnitine—Convulsion—Prednisolone—atopic dermatitis	0.000739	0.00127	CcSEcCtD
L-Carnitine—Hypertension—Prednisolone—atopic dermatitis	0.000736	0.00127	CcSEcCtD
L-Carnitine—Arrhythmia—Dexamethasone—atopic dermatitis	0.00073	0.00125	CcSEcCtD
L-Carnitine—Arrhythmia—Betamethasone—atopic dermatitis	0.00073	0.00125	CcSEcCtD
L-Carnitine—Convulsion—Hydrocortisone—atopic dermatitis	0.000722	0.00124	CcSEcCtD
L-Carnitine—Dizziness—Tacrolimus—atopic dermatitis	0.000721	0.00124	CcSEcCtD
L-Carnitine—Hypertension—Hydrocortisone—atopic dermatitis	0.000719	0.00124	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisone—atopic dermatitis	0.000716	0.00123	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000712	0.00619	CbGpPWpGaD
L-Carnitine—Haemorrhage—Prednisone—atopic dermatitis	0.000712	0.00122	CcSEcCtD
L-Carnitine—Myalgia—Hydrocortisone—atopic dermatitis	0.000709	0.00122	CcSEcCtD
L-Carnitine—Anxiety—Hydrocortisone—atopic dermatitis	0.000707	0.00121	CcSEcCtD
L-Carnitine—Vertigo—Triamcinolone—atopic dermatitis	0.000705	0.00121	CcSEcCtD
L-Carnitine—Vertigo—Methylprednisolone—atopic dermatitis	0.000703	0.00121	CcSEcCtD
L-Carnitine—Vomiting—Tacrolimus—atopic dermatitis	0.000693	0.00119	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000691	0.006	CbGpPWpGaD
L-Carnitine—Rash—Tacrolimus—atopic dermatitis	0.000687	0.00118	CcSEcCtD
L-Carnitine—Dermatitis—Tacrolimus—atopic dermatitis	0.000687	0.00118	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000685	0.00595	CbGpPWpGaD
L-Carnitine—Cough—Triamcinolone—atopic dermatitis	0.000684	0.00118	CcSEcCtD
L-Carnitine—Headache—Tacrolimus—atopic dermatitis	0.000683	0.00117	CcSEcCtD
L-Carnitine—Convulsion—Triamcinolone—atopic dermatitis	0.00068	0.00117	CcSEcCtD
L-Carnitine—Tachycardia—Prednisolone—atopic dermatitis	0.000679	0.00117	CcSEcCtD
L-Carnitine—Convulsion—Methylprednisolone—atopic dermatitis	0.000678	0.00117	CcSEcCtD
L-Carnitine—Hypertension—Triamcinolone—atopic dermatitis	0.000677	0.00116	CcSEcCtD
L-Carnitine—Hypertension—Methylprednisolone—atopic dermatitis	0.000676	0.00116	CcSEcCtD
L-Carnitine—Infection—Hydrocortisone—atopic dermatitis	0.000675	0.00116	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL1B—atopic dermatitis	0.000674	0.00586	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL2—atopic dermatitis	0.000672	0.00584	CbGpPWpGaD
L-Carnitine—Myalgia—Triamcinolone—atopic dermatitis	0.000668	0.00115	CcSEcCtD
L-Carnitine—Myalgia—Methylprednisolone—atopic dermatitis	0.000666	0.00114	CcSEcCtD
L-Carnitine—Eye disorder—Prednisone—atopic dermatitis	0.000665	0.00114	CcSEcCtD
L-Carnitine—Anxiety—Methylprednisolone—atopic dermatitis	0.000664	0.00114	CcSEcCtD
L-Carnitine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000664	0.00114	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000659	0.00573	CbGpPWpGaD
L-Carnitine—Anorexia—Hydrocortisone—atopic dermatitis	0.000648	0.00111	CcSEcCtD
L-Carnitine—Nausea—Tacrolimus—atopic dermatitis	0.000647	0.00111	CcSEcCtD
L-Carnitine—Angiopathy—Prednisone—atopic dermatitis	0.000646	0.00111	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000644	0.0056	CbGpPWpGaD
L-Carnitine—Vertigo—Betamethasone—atopic dermatitis	0.000639	0.0011	CcSEcCtD
L-Carnitine—Vertigo—Dexamethasone—atopic dermatitis	0.000639	0.0011	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisone—atopic dermatitis	0.000636	0.00109	CcSEcCtD
L-Carnitine—Infection—Triamcinolone—atopic dermatitis	0.000636	0.00109	CcSEcCtD
L-Carnitine—Hypotension—Hydrocortisone—atopic dermatitis	0.000635	0.00109	CcSEcCtD
L-Carnitine—Infection—Methylprednisolone—atopic dermatitis	0.000635	0.00109	CcSEcCtD
L-Carnitine—Insomnia—Prednisolone—atopic dermatitis	0.00063	0.00108	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—atopic dermatitis	0.000627	0.00545	CbGpPWpGaD
L-Carnitine—Paraesthesia—Prednisolone—atopic dermatitis	0.000625	0.00107	CcSEcCtD
L-Carnitine—Tachycardia—Triamcinolone—atopic dermatitis	0.000625	0.00107	CcSEcCtD
L-Carnitine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000623	0.00107	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000619	0.00106	CcSEcCtD
L-Carnitine—Convulsion—Dexamethasone—atopic dermatitis	0.000617	0.00106	CcSEcCtD
L-Carnitine—Convulsion—Betamethasone—atopic dermatitis	0.000617	0.00106	CcSEcCtD
L-Carnitine—Insomnia—Hydrocortisone—atopic dermatitis	0.000615	0.00106	CcSEcCtD
L-Carnitine—Hypertension—Dexamethasone—atopic dermatitis	0.000614	0.00106	CcSEcCtD
L-Carnitine—Hypertension—Betamethasone—atopic dermatitis	0.000614	0.00106	CcSEcCtD
L-Carnitine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.00061	0.00105	CcSEcCtD
L-Carnitine—Myalgia—Dexamethasone—atopic dermatitis	0.000606	0.00104	CcSEcCtD
L-Carnitine—Myalgia—Betamethasone—atopic dermatitis	0.000606	0.00104	CcSEcCtD
L-Carnitine—Anxiety—Dexamethasone—atopic dermatitis	0.000604	0.00104	CcSEcCtD
L-Carnitine—Anxiety—Betamethasone—atopic dermatitis	0.000604	0.00104	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—PPARA—atopic dermatitis	0.000603	0.00524	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CD4—atopic dermatitis	0.000602	0.00523	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000601	0.00522	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.0006	0.00522	CbGpPWpGaD
L-Carnitine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000598	0.00103	CcSEcCtD
L-Carnitine—Hypotension—Methylprednisolone—atopic dermatitis	0.000597	0.00103	CcSEcCtD
L-Carnitine—Pain—Prednisolone—atopic dermatitis	0.000595	0.00102	CcSEcCtD
L-Carnitine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000591	0.00102	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000588	0.00511	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000588	0.00511	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000587	0.00101	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000583	0.001	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000582	0.001	CcSEcCtD
L-Carnitine—Pain—Hydrocortisone—atopic dermatitis	0.000581	0.000999	CcSEcCtD
L-Carnitine—Insomnia—Triamcinolone—atopic dermatitis	0.000579	0.000995	CcSEcCtD
L-Carnitine—Insomnia—Methylprednisolone—atopic dermatitis	0.000578	0.000993	CcSEcCtD
L-Carnitine—Infection—Dexamethasone—atopic dermatitis	0.000577	0.000991	CcSEcCtD
L-Carnitine—Infection—Betamethasone—atopic dermatitis	0.000577	0.000991	CcSEcCtD
L-Carnitine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000575	0.000988	CcSEcCtD
L-Carnitine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000574	0.000985	CcSEcCtD
L-Carnitine—Anaemia—Prednisone—atopic dermatitis	0.000573	0.000984	CcSEcCtD
L-Carnitine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000571	0.000981	CcSEcCtD
L-Carnitine—Tachycardia—Betamethasone—atopic dermatitis	0.000567	0.000974	CcSEcCtD
L-Carnitine—Tachycardia—Dexamethasone—atopic dermatitis	0.000567	0.000974	CcSEcCtD
L-Carnitine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000563	0.000968	CcSEcCtD
L-Carnitine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000562	0.000966	CcSEcCtD
L-Carnitine—Vertigo—Prednisone—atopic dermatitis	0.000557	0.000957	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000556	0.000955	CcSEcCtD
L-Carnitine—Anorexia—Dexamethasone—atopic dermatitis	0.000554	0.000951	CcSEcCtD
L-Carnitine—Anorexia—Betamethasone—atopic dermatitis	0.000554	0.000951	CcSEcCtD
L-Carnitine—Pain—Triamcinolone—atopic dermatitis	0.000547	0.000941	CcSEcCtD
L-Carnitine—Hypotension—Betamethasone—atopic dermatitis	0.000543	0.000933	CcSEcCtD
L-Carnitine—Hypotension—Dexamethasone—atopic dermatitis	0.000543	0.000933	CcSEcCtD
L-Carnitine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000537	0.000923	CcSEcCtD
L-Carnitine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000537	0.000923	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—atopic dermatitis	0.000537	0.000923	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000536	0.00465	CbGpPWpGaD
L-Carnitine—Hypertension—Prednisone—atopic dermatitis	0.000535	0.000919	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000529	0.000909	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000529	0.000909	CcSEcCtD
L-Carnitine—Myalgia—Prednisone—atopic dermatitis	0.000528	0.000907	CcSEcCtD
L-Carnitine—Anxiety—Prednisone—atopic dermatitis	0.000526	0.000903	CcSEcCtD
L-Carnitine—Insomnia—Betamethasone—atopic dermatitis	0.000525	0.000903	CcSEcCtD
L-Carnitine—Insomnia—Dexamethasone—atopic dermatitis	0.000525	0.000903	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000525	0.00456	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000522	0.000897	CcSEcCtD
L-Carnitine—Paraesthesia—Betamethasone—atopic dermatitis	0.000522	0.000896	CcSEcCtD
L-Carnitine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000522	0.000896	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GLB1—atopic dermatitis	0.00052	0.00451	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000515	0.00447	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000513	0.000881	CcSEcCtD
L-Carnitine—Dyspepsia—Betamethasone—atopic dermatitis	0.000511	0.000878	CcSEcCtD
L-Carnitine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000511	0.000878	CcSEcCtD
L-Carnitine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000506	0.000869	CcSEcCtD
L-Carnitine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000505	0.000868	CcSEcCtD
L-Carnitine—Decreased appetite—Betamethasone—atopic dermatitis	0.000505	0.000868	CcSEcCtD
L-Carnitine—Decreased appetite—Dexamethasone—atopic dermatitis	0.000505	0.000868	CcSEcCtD
L-Carnitine—Infection—Prednisone—atopic dermatitis	0.000503	0.000863	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000501	0.000862	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000501	0.000862	CcSEcCtD
L-Carnitine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000501	0.000861	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ADSL—atopic dermatitis	0.000498	0.00433	CbGpPWpGaD
L-Carnitine—Pain—Dexamethasone—atopic dermatitis	0.000497	0.000853	CcSEcCtD
L-Carnitine—Pain—Betamethasone—atopic dermatitis	0.000497	0.000853	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—atopic dermatitis	0.000494	0.000848	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000489	0.00425	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TNF—atopic dermatitis	0.000489	0.00425	CbGpPWpGaD
L-Carnitine—Asthenia—Hydrocortisone—atopic dermatitis	0.000488	0.000838	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000485	0.00422	CbGpPWpGaD
L-Carnitine—Anorexia—Prednisone—atopic dermatitis	0.000482	0.000828	CcSEcCtD
L-Carnitine—Pruritus—Hydrocortisone—atopic dermatitis	0.000481	0.000826	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000475	0.000816	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000475	0.000816	CcSEcCtD
L-Carnitine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000472	0.00081	CcSEcCtD
L-Carnitine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000471	0.000809	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000468	0.00407	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.000466	0.00405	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000465	0.00404	CbGpPWpGaD
L-Carnitine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000465	0.000799	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000461	0.000792	CcSEcCtD
L-Carnitine—Dizziness—Prednisolone—atopic dermatitis	0.00046	0.000791	CcSEcCtD
L-Carnitine—Asthenia—Triamcinolone—atopic dermatitis	0.000459	0.000789	CcSEcCtD
L-Carnitine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000459	0.000789	CcSEcCtD
L-Carnitine—Body temperature increased—Betamethasone—atopic dermatitis	0.000459	0.000789	CcSEcCtD
L-Carnitine—Abdominal pain—Betamethasone—atopic dermatitis	0.000459	0.000789	CcSEcCtD
L-Carnitine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000459	0.000789	CcSEcCtD
L-Carnitine—Asthenia—Methylprednisolone—atopic dermatitis	0.000458	0.000787	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—atopic dermatitis	0.000458	0.000786	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000455	0.00396	CbGpPWpGaD
L-Carnitine—Paraesthesia—Prednisone—atopic dermatitis	0.000454	0.00078	CcSEcCtD
L-Carnitine—Pruritus—Triamcinolone—atopic dermatitis	0.000453	0.000778	CcSEcCtD
L-Carnitine—Pruritus—Methylprednisolone—atopic dermatitis	0.000452	0.000776	CcSEcCtD
L-Carnitine—Dizziness—Hydrocortisone—atopic dermatitis	0.00045	0.000772	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.000447	0.00388	CbGpPWpGaD
L-Carnitine—Dyspepsia—Prednisone—atopic dermatitis	0.000445	0.000765	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—atopic dermatitis	0.00044	0.000756	CcSEcCtD
L-Carnitine—Rash—Prednisolone—atopic dermatitis	0.000439	0.000754	CcSEcCtD
L-Carnitine—Dermatitis—Prednisolone—atopic dermatitis	0.000438	0.000753	CcSEcCtD
L-Carnitine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000437	0.000751	CcSEcCtD
L-Carnitine—Headache—Prednisolone—atopic dermatitis	0.000436	0.000749	CcSEcCtD
L-Carnitine—Constipation—Prednisone—atopic dermatitis	0.000433	0.000743	CcSEcCtD
L-Carnitine—Vomiting—Hydrocortisone—atopic dermatitis	0.000432	0.000743	CcSEcCtD
L-Carnitine—Rash—Hydrocortisone—atopic dermatitis	0.000429	0.000737	CcSEcCtD
L-Carnitine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000428	0.000736	CcSEcCtD
L-Carnitine—Headache—Hydrocortisone—atopic dermatitis	0.000426	0.000732	CcSEcCtD
L-Carnitine—Dizziness—Triamcinolone—atopic dermatitis	0.000423	0.000727	CcSEcCtD
L-Carnitine—Dizziness—Methylprednisolone—atopic dermatitis	0.000422	0.000726	CcSEcCtD
L-Carnitine—Asthenia—Dexamethasone—atopic dermatitis	0.000417	0.000716	CcSEcCtD
L-Carnitine—Asthenia—Betamethasone—atopic dermatitis	0.000417	0.000716	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000414	0.000711	CcSEcCtD
L-Carnitine—Nausea—Prednisolone—atopic dermatitis	0.000413	0.00071	CcSEcCtD
L-Carnitine—Pruritus—Dexamethasone—atopic dermatitis	0.000411	0.000706	CcSEcCtD
L-Carnitine—Pruritus—Betamethasone—atopic dermatitis	0.000411	0.000706	CcSEcCtD
L-Carnitine—Vomiting—Triamcinolone—atopic dermatitis	0.000407	0.000699	CcSEcCtD
L-Carnitine—Vomiting—Methylprednisolone—atopic dermatitis	0.000406	0.000698	CcSEcCtD
L-Carnitine—Nausea—Hydrocortisone—atopic dermatitis	0.000404	0.000694	CcSEcCtD
L-Carnitine—Rash—Triamcinolone—atopic dermatitis	0.000404	0.000693	CcSEcCtD
L-Carnitine—Dermatitis—Triamcinolone—atopic dermatitis	0.000403	0.000693	CcSEcCtD
L-Carnitine—Rash—Methylprednisolone—atopic dermatitis	0.000403	0.000692	CcSEcCtD
L-Carnitine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000402	0.000691	CcSEcCtD
L-Carnitine—Headache—Triamcinolone—atopic dermatitis	0.000401	0.000689	CcSEcCtD
L-Carnitine—Headache—Methylprednisolone—atopic dermatitis	0.0004	0.000688	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—atopic dermatitis	0.0004	0.000687	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—atopic dermatitis	0.0004	0.000687	CcSEcCtD
L-Carnitine—Diarrhoea—Betamethasone—atopic dermatitis	0.000397	0.000683	CcSEcCtD
L-Carnitine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000397	0.000683	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL6—atopic dermatitis	0.000395	0.00343	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000389	0.00338	CbGpPWpGaD
L-Carnitine—Dizziness—Dexamethasone—atopic dermatitis	0.000384	0.00066	CcSEcCtD
L-Carnitine—Dizziness—Betamethasone—atopic dermatitis	0.000384	0.00066	CcSEcCtD
L-Carnitine—Nausea—Triamcinolone—atopic dermatitis	0.00038	0.000653	CcSEcCtD
L-Carnitine—Nausea—Methylprednisolone—atopic dermatitis	0.000379	0.000652	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000379	0.00329	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisone—atopic dermatitis	0.000373	0.00064	CcSEcCtD
L-Carnitine—Vomiting—Betamethasone—atopic dermatitis	0.000369	0.000635	CcSEcCtD
L-Carnitine—Vomiting—Dexamethasone—atopic dermatitis	0.000369	0.000635	CcSEcCtD
L-Carnitine—Rash—Dexamethasone—atopic dermatitis	0.000366	0.000629	CcSEcCtD
L-Carnitine—Rash—Betamethasone—atopic dermatitis	0.000366	0.000629	CcSEcCtD
L-Carnitine—Dermatitis—Dexamethasone—atopic dermatitis	0.000366	0.000629	CcSEcCtD
L-Carnitine—Dermatitis—Betamethasone—atopic dermatitis	0.000366	0.000629	CcSEcCtD
L-Carnitine—Headache—Dexamethasone—atopic dermatitis	0.000364	0.000625	CcSEcCtD
L-Carnitine—Headache—Betamethasone—atopic dermatitis	0.000364	0.000625	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—atopic dermatitis	0.000363	0.000624	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—GLB1—atopic dermatitis	0.00036	0.00313	CbGpPWpGaD
L-Carnitine—Pruritus—Prednisone—atopic dermatitis	0.000358	0.000615	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000353	0.00307	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000348	0.00302	CbGpPWpGaD
L-Carnitine—Diarrhoea—Prednisone—atopic dermatitis	0.000346	0.000595	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ADSL—atopic dermatitis	0.000345	0.003	CbGpPWpGaD
L-Carnitine—Nausea—Dexamethasone—atopic dermatitis	0.000345	0.000593	CcSEcCtD
L-Carnitine—Nausea—Betamethasone—atopic dermatitis	0.000345	0.000593	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—atopic dermatitis	0.00034	0.00295	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000335	0.00291	CbGpPWpGaD
L-Carnitine—Dizziness—Prednisone—atopic dermatitis	0.000334	0.000575	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.000324	0.00282	CbGpPWpGaD
L-Carnitine—Vomiting—Prednisone—atopic dermatitis	0.000322	0.000553	CcSEcCtD
L-Carnitine—Rash—Prednisone—atopic dermatitis	0.000319	0.000548	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—atopic dermatitis	0.000319	0.000547	CcSEcCtD
L-Carnitine—Headache—Prednisone—atopic dermatitis	0.000317	0.000544	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000314	0.00272	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPARA—atopic dermatitis	0.000308	0.00267	CbGpPWpGaD
L-Carnitine—Nausea—Prednisone—atopic dermatitis	0.0003	0.000516	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000282	0.00245	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000274	0.00238	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000262	0.00228	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000262	0.00227	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARA—atopic dermatitis	0.000262	0.00227	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARA—atopic dermatitis	0.000262	0.00227	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000262	0.00227	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GLB1—atopic dermatitis	0.000239	0.00207	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000237	0.00206	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADSL—atopic dermatitis	0.000229	0.00199	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—atopic dermatitis	0.000214	0.00186	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00018	0.00156	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARA—atopic dermatitis	0.000169	0.00147	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000169	0.00146	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000127	0.0011	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GLB1—atopic dermatitis	0.000126	0.00109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADSL—atopic dermatitis	0.00012	0.00105	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARA—atopic dermatitis	0.000117	0.00102	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000115	0.000996	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.15e-05	0.000795	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.7e-05	0.000756	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARA—atopic dermatitis	7.74e-05	0.000673	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARA—atopic dermatitis	4.07e-05	0.000354	CbGpPWpGaD
